The U.S. Department of Justice (DOJ) and 18 state attorneys general (AG) announced a settlement with Boston-based QOL Medical, LLC (QOL) and its ...
Sucraid is an FDA-approved therapy for the rare genetic condition Congenital Sucrase-Isomaltase Deficiency (CSID), but it comes with a hefty price tag. QOL and Cooper have admitted that they ...
This genetic variation—enzymatic sucrase-isomaltase (SI) deficiency—could lead to dietary sugars remaining undigested by the ...
MassHealth receives $1.4 million from a $47 million settlement with QOL Medical over alleged kickback schemes involving ...
Learn what sucrase deficiency is along with its causes and types, and discover how to manage it, with tips from a doctor and a dietitian.
According to research, taking the supplement can help enhance digestion and easy gut problems like bloating, gas and stomach aches ...